Discontinuous to Continuous Therapy with 0.2 μg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)

被引：0
|
作者：
Adams, Olufemi E. [1 ]
Schechet, Sidney [1 ]
Hariprasad, Seenu [1 ]
机构：
[1] Univ Chicago, Ophthalmol, Chicago, IL 60637 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2614
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema
    Merrill, Pauline T.
    Holekamp, Nancy
    Roth, Daniel
    Kasper, Jonathan
    Grigorian, Ruben
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 248 : 16 - 23
  • [42] Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes
    La Mantia, Alberto
    Hawrami, Alan
    Laviers, Heidi
    Patra, Sudesima
    Zambarakji, Hadi
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (12) : 1951 - 1956
  • [43] Iluvien (Fluocinolone Acetonide 0.19mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 293 - 305
  • [44] Long-term visual outcomes based on baseline vision in patients with chronic diabetic macular edema (DME) treated with fluocinolone acetonide (FAc)
    Campochiaro, Peter A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [45] A retrospective evaluation of the efficacy and safety of fluocinolone acetonide 0.2 μg implant in patients with chronic diabetic macular edema with insufficient response to other therapies
    Meireles, Angelina
    Coelho, Joao
    Pessoa, Bernardete
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [46] Fluocinolone acetonide implant in diabetic macular edema: International experts' panel consensus guidelines and treatment algorithm
    Kodjikian, Laurent
    Bandello, Francesco
    de Smet, Marc
    Dot, Corrine
    Zarranz-Ventura, Javier
    Loewenstein, Anat
    Sudhalkar, Aditya
    Bilgic, Alper
    Cunha-Vaz, Jose
    Dirven, Werner
    Behar-Cohen, Francine
    Mathis, Thibaud
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (04) : 1890 - 1899
  • [47] CASE SERIES EVALUATING INTRAVITREAL FLUOCINOLONE IMPLANT (ILUVIEN®; [FAc]) IN THE TREATMENT OF PATIENTS WITH CHRONIC DIABETIC MACULAR EDEMA ( DME) INSUFFICIENTLY RESPONSIVE TO CURRENT TREATMENT OPTIONS
    Patel, T.
    Goldsmith, C.
    Raja, M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (03) : E24 - E25
  • [48] FLUOCINOLONE ACETONIDE 0.2μg/DAY (ILUVIEN®) FOR THE TREATMENT OF CHRONIC DIABETIC MACULAR OEDEMA: AN ITALIAN REAL-WORLD EXPERIENCE
    Capone, L.
    Lattanzio, R.
    Bandello, F.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP17 - NP17
  • [49] Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema
    Pessoa, Bernardete
    Coelho, Joao
    Correia, Nuno
    Ferreira, Natalia
    Beirao, Melo
    Meireles, Angelina
    OPHTHALMIC RESEARCH, 2018, 59 (02) : 68 - 75
  • [50] Two-year interim safety results of the 0.2 μg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
    Mansour, Sam E.
    Kiernan, Daniel F.
    Roth, Daniel B.
    Eichenbaum, David
    Holekamp, Nancy M.
    Kaba, Samer
    Werts, Erica
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (03) : 414 - 419
12345